Germline-somatic liaison dictates cancer subtype via de novo steroid biosynthesis
RNA-seq (gene expression) · human · 29 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Topic
- Prostate cancerThis series is part of our curated briefing on it.
- Samples
- 29 samples: 27 distinct titles, 2 of them repeatedGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Germline-Somatic Liaison Dictates Cancer Subtypes via de novo Steroid BiosynthesisCancer discovery · 2025
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE293478_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1244773 and SRA study SRP575755. Searching any of these in the dataset finder brings you back here.
How we read this: Read from 29 sample titles: 27 distinct titles with little repetition. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8883107 PC-3, clone 5, AA, rep1
- GSM8883108 PC-3, clone 9, AA, rep2
- GSM8883109 PC-3, clone 9, AA, rep3
- GSM8883110 PC-3, clone 5, AA_AR_DHT
- GSM8883111 PC-3, clone 5, AA_AR_EtOH
- GSM8883112 PC-3, clone 1, AG, rep1
- GSM8883113 PC-3, clone 1, AG, rep2
- GSM8883114 PC-3, clone 1, GG, rep1
- GSM8883115 PC-3, clone 9, GG, rep2
- GSM8883116 PC-3, clone 1, GG_AR_DHT
- GSM8883117 PC-3, clone 1, GG_AR_EtOH
- GSM8883118 LnCap, LvCas9_pUC19_sgRNA_E_px330_sgRNA_A_S18
- GSM8883119 LnCap, LvCas9_pUC19_sgRNA_scramb_S15
- GSM8883120 LnCap, LvCas9_pUC19_sgRNA_up2_down3_S16
- GSM8883121 PC-3, LvCas9_pSp_sgRNA_B_cloneB15_S8
- GSM8883122 PC-3, LvCas9_pSp_sgRNA_B_cloneB4_S6
- GSM8883123 PC-3, LvCas9_pSp_sgRNA_B_cloneB5_S7
- GSM8883124 PC-3, LvCas9_pSp_sgRNA_C_cloneC14_S10
- GSM8883125 PC-3, LvCas9_pSp_sgRNA_C_cloneC3_S9
- GSM8883126 PC-3, LvCas9_pSp_sgRNA_scramb_CTRL1_S5
- GSM8883127 PC-3, LvCas9_px330_sgRNA_A_clone_PA3_5_S13
- GSM8883128 PC-3, LvCas9_px330_sgRNA_A_clone_PA3_S12
- GSM8883129 PC-3, LvCas9_px330_sgRNA_A_clone_PA4_6_S14
- GSM8883130 PC-3, LvCas9_px330_sgRNA_scramb_CTRL3_S11
- GSM8883131 PC-3, pSpCas9_Zhang_pUC19_sgRNA_A_sgRNA_E_S17
- GSM8883132 PC-3, pSpCas9_Zhang_pUC19_sgRNA_scramb_S1
- GSM8883133 PC-3, pSpCas9_Zhang_pUC19_sgRNA_up2_down3_clone12_S3
- GSM8883134 PC-3, pSpCas9_Zhang_pUC19_sgRNA_up2_down3_clone15_S4
- GSM8883135 PC-3, pSpCas9_Zhang_pUC19_sgRNA_up2_down3_clone3_S2
- GSE115501 RNA sequencing on circulating tumor cells from prostate cancer patients 136 samples same disease briefing
- GSE222467 The RNA binding proteins LARP4A and LARP4B promote tumour growth and metastasis in prostate cancer and osteosarcoma 12 samples same disease briefing
- GSE242541 ONECUT2 is a druggable driver of luminal to basal breast cancer plasticity 12 samples same disease briefing
- GSE300947 A novel six-biomarker panel identified from male breast cancer-associated fibroblasts demonstrates prognostic power for prostate tumors 6 samples same disease briefing
- GSE71008 Plasma extracellular RNA profiles in healthy and cancer patients 192 samples same disease briefing
- GSE120181 Human prostate cancer cell line, 22Rv1: Control vs. luteolin treatment 2 samples same disease briefing
- GSE254558 Chemotherapy-driven de novo Wnt pathway activation dictates a dynamic shift to a drug-tolerant state in breast cancer cells 46 samples shares dictates, novo
- GSE314127 Ectopic expression of cytosolic DHODH uncouples de novo pyrimidine biosynthesis from mitochondrial electron transport 16 samples shares biosynthesis, novo
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.